Blue Trust Inc
RPRX icon

Blue Trust Inc’s Royalty Pharma RPRX Stock Holding History

Blue Trust Inc’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.56K Sell
44
-596
-93% -$35.2K ﹤0.01% 1994
2026
Q2 		$35.9K Sell
640
-49
-7% -$2.55K ﹤0.01% 1481
2026
Q1 		$33.1K Buy
689
+437
+173% +$19.1K ﹤0.01% 1483
2025
Q4 		$9.7K Buy
252
+166
+193% +$6.33K ﹤0.01% 1868
2025
Q3 		$3.04K Buy
86
+34
+65% +$1.23K ﹤0.01% 2081
2025
Q2 		$1.87K Sell
52
-157
-75% -$5.2K ﹤0.01% 2135
2025
Q1 		$6.51K Buy
209
+52
+33% +$1.65K ﹤0.01% 2054
2024
Q4 		$4K Sell
157
-1,046
-87% -$27.7K ﹤0.01% 2123
2024
Q3 		$31.7K Buy
1,203
+943
+363% +$26.1K ﹤0.01% 1759
2024
Q2 		$7.9K Buy
260
+247
+1,900% +$6.85K ﹤0.01% 2021
2024
Q1 		$395 Sell
13
-63
-83% -$1.86K ﹤0.01% 2029
2023
Q4 		$2K Buy
+76
New +$2.09K ﹤0.01% 2204
2023
Q3 		– Sell
-23
Closed -$1K – 2254
2023
Q2 		$1K Sell
23
-31
-57% -$1.05K ﹤0.01% 1914
2023
Q1 		$2K Sell
54
-7
-11% -$260 ﹤0.01% 2043
2022
Q4 		$2K Hold
61
– – ﹤0.01% 1956
2022
Q3 		$3K Hold
61
– – ﹤0.01% 1714
2022
Q2 		$2K Buy
+61
New +$2.5K ﹤0.01% 1691

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Todd Asset Management
Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Hosking Partners
Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return
Kepler Cheuvreux
Kepler Cheuvreux Nyon $1.65B AUM 36.86% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Blue Trust Inc's RPRX Position: Q3 2026 in Review

Blue Trust Inc reduced its Royalty Pharma (RPRX) stake by 93% in Q3 2026, selling an estimated $35.2K and leaving 44 shares worth $2.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

Blue Trust Inc first reported a position in RPRX in Q2 2022 and has held it in 17 quarters since. The position peaked at $35.9K in Q2 2026. 179 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Blue Trust Inc held 44 shares of Royalty Pharma worth $2.56K as of Q3 2026.
  • Blue Trust Inc sold 596 Royalty Pharma shares in Q3 2026, an estimated $35.2K.
  • Royalty Pharma made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #1994 holding.
  • Blue Trust Inc first reported a position in Royalty Pharma in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Royalty Pharma position peaked at $35.9K in Q2 2026.
  • 179 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.